Skip to content

Influence of Nutritional and Inflammational Status on Survival of Hemodialysis Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00410137
Enrollment
100
Registered
2006-12-12
Start date
2006-03-31
Completion date
2008-04-30
Last updated
2006-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Inflammation

Brief summary

prospective longitudinal measurements of nutritional status parameters (body composition by BIA, anthropometry and biochemical indexes), inflammatory response (CRP, inflammatory cytokines (IL-1, IL-6, IL-10),IGF-1, leptin and NOx blood levels) and morbidity and mortality data collection over 2 year period in patients receiving chronic hemodialysis.

Interventions

None listed

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female, age \> 18 years, in chronic hemodialysis treatment at least 3 months * Stable and adequate hemodialysis treatment three months prior to participation in study as defined by Kt/V \> 1.2 and/or hemodialysis performed 4 hours 3 times weekly * Patients with normal hydration status (edema-free), with no neuro-muscular diseases * Informed consent obtained before any trial-related activities

Exclusion criteria

* Patients with edema, pleural effusion or ascites at their initial assessment * Patients with active malignant disease or liver cirrhosis * Patients with neuro-muscular diseases * Patients on chronic treatment with steroids on doses \> 10 mg/day Prednisone (or equivalent) * Patients treated with immunosuppressive agents * Patients suffering from * Acute vasculitis * Severe systemic infections * Heart failure (NYHA class III-IV) * The receipt of any investigational drug within 1 month prior to initiating of this study

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026